Merck & Co., Inc. (MRK) To absorb $1.1 Billion In Net debt On Cubist Pharmaceuticals Inc. (CBST) Acquisition
Merck & Co., Inc.
Posts Tagged ‘NASDAQ:CBST’
Trius Therapeutics, Inc. (TSRX), Cubist Pharmaceuticals Inc (CBST), Pfizer Inc. (PFE): A Portfolio Of Potential
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Hedge Funds Are Dumping Dr. Reddy’s Laboratories Limited (ADR) (RDY)
To many of your fellow Dr.
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
The Medicines Company (MDCO), United Therapeutics Corporation (UTHR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age.
Hedge Funds Are Crazy About Endo Health Solutions Inc (ENDP)
To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)
In today’s marketplace, there are tons of indicators investors can use to track the equity markets.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): How Could This Deal Shake Up an Entire Industry?
With two simultaneous moves that have set the pharmaceutical world on fire, Cubist Pharmaceuticals Inc (NASDAQ:CBST) has triumphantly announced its arrival on the global stage...
Cubist Pharmaceuticals Inc (CBST), Forest Laboratories, Inc. (FRX): Marketed Drugs, Strong Pipeline, Long Term Growth Stock
In June this year, a drug candidate from Cubist Pharmaceuticals Inc (NASDAQ:CBST) received fast track status from the FDA.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Cubist Pharmaceuticals Inc (CBST), Optimer Pharmaceuticals, Inc. (OPTR), Trius Therapeutics, Inc. (TSRX): Will This Biotech Company’s Big Bet Pay Off?
Cubist Pharmaceuticals Inc (NASDAQ:CBST) surged 10% on July 31, after the company acquired two antibiotic makers, Optimer Pharmaceuticals, Inc.
Anatomy of an Earnings Jump: Cubist Pharmaceuticals Inc (CBST)
Shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) exploded upward on Friday, finishing up over 9%.
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren’t Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March.
Merck & Co., Inc. (MRK): Don’t Invest in Biotech IPOs Until You Read This
A spate of 10 biotechs went public this year, raising over $725 million.
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are perceived as slow, old investment tools of the past.
Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (CBST)
Cubist Pharmaceuticals Inc (NASDAQ:CBST) was in 22 hedge funds' portfolio at the end of March.
Should You Buy The Medicines Company (MDCO)?
At the moment, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading activity.
The Medicines Company (MDCO): Is There a Future for Small Pharma?
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens.
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
GlaxoSmithKline plc (ADR) (GSK) & Three Humongous Healthcare Stocks This Week
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (NASDAQ:CBST)
Is Cubist Pharmaceuticals Inc (NASDAQ:CBST) a buy right now? Prominent investors are taking a bearish view.
Profit From These Rapidly Growing Small Caps: 3D Systems Corporation (DDD), Cubist Pharmaceuticals Inc (CBST), Align Technology, Inc. (ALGN)
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Buy, Sell, or Hold: Astex Pharmaceuticals, Inc. (ASTX)
When considering any stock for your portfolio, don't be swayed by just the positives. Examine its pros and cons and decide whether its possible upside outweighs its risks.
